about
Never Events in UK General Practice: A Survey of the Views of General Practitioners on Their Frequency and Acceptability as a Safety Improvement Approach.Early assessment by a mobile stroke team: a randomised controlled trial.Alkylation of sperm DNA is associated with male factor infertility and a reduction in the proportion of oocytes fertilised during assisted reproduction.Temporal trends in antidepressant prescribing to children in UK primary care, 2000-2015.Application of a tool for the evaluation of public and patient involvement in research.Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional StudyMissed diagnostic opportunities and English general practice: a study to determine their incidence, confounding and contributing factors and potential impact on patients through retrospective review of electronic medical recordsExamining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research DatalinkIsocyanate exposure and asthma in the UK vehicle repair industryEpidemiology and trends in male subfertility.Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.Contact allergy resulting from the use of acrylate nails is increasing in both users and those who are occupationally exposed.Worldwide trends in incidence in occupational allergy and asthma.Incidence rates of occupational diseases in the Dutch construction sector, 2010-2014.The impact of national-level interventions to improve hygiene on the incidence of irritant contact dermatitis in healthcare workers: changes in incidence from 1996 to 2012 and interrupted times series analysis.A refined QSAR model for prediction of chemical asthma hazard.The Health and Occupation Research Network: An Evolving Surveillance SystemPesticide exposure and screen-positive neuropsychiatric disease in British sheep farmers.The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.Medically reported work-related ill-health in the UK agricultural sector.Occupational allergic contact dermatitis and major allergens in France: temporal trends for the period 2001-2010.Production and isolation of large quantities of monoclonal antibody using serum-free medium and fast protein liquid chromatography.Chest physician-reported, work-related, long-latency respiratory disease in Great Britain.Accelerator-free gloves as alternatives in cases of glove allergy in healthcare workers.Development and piloting of a survey to estimate the frequency and nature of potentially harmful preventable problems in primary care from a UK patient's perspective.The incidence of medically reported work-related ill health in the UK construction industry.Development of mechanism-based structural alerts for respiratory sensitization hazard identification.Identifying primary care patient safety research priorities in the UK: a James Lind Alliance Priority Setting Partnership.Frequency and nature of potentially harmful preventable problems in primary care from the patient's perspective with clinician review: a population-level survey in Great Britain.Authors’ reply to UptonEffectiveness of the European chromium(vi ) directive for cement implementation on occupational allergic contact dermatitis occurrence: assessment in France and the U.KAssessing the impact of national level interventions on workplace respiratory disease in the UK: part 1—changes in workplace exposure legislation and market forcesEvaluating interventions aimed at reducing occupational exposure to latex and rubber glove allergensAcute ill-health in sheep farmers following use of pesticidesHas European Union legislation to reduce exposure to chromate in cement been effective in reducing the incidence of allergic contact dermatitis attributed to chromate in the UK?[36] Use of polyacrylamide-derivatized antibody in dextran-poly(ethylene glycol) systemsDevelopment of a general ligand for immunoaffinity partitioning in two phase aqueous polymer systemsA fluorometric assay of the degree of modification of protein primary amines with polyethylene glycolCorrection to: Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General PracticeUse of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis
P50
Q30491545-318C4246-7206-45A4-A126-7B1939450770Q33390009-D33486A0-BF07-42BE-BA8D-2C49BC645018Q33390348-2CC393A8-B64F-4AC3-8E8C-C040FFEBFE6DQ33763721-592845C8-CAAA-468F-B206-2085105D71D6Q35179651-55758B1C-6AB5-4581-82C7-1F1C1681E02DQ35802541-A3FC5EFA-6848-43CF-8188-EB3E710A0D6DQ35899370-86B0717F-C704-4BE2-A728-8939C8A1E137Q36246213-3D59B49F-1B8F-46C5-B500-A6DEA14E0903Q36349879-E7A7745B-6310-46D3-A20A-208BD089B143Q37813645-144E112E-49FC-4450-AA50-B66281AB67ABQ38691294-27556B99-C0A2-4E14-903A-E318FE5B4F82Q38695828-5B6FEA5F-BD09-4EED-9444-E72C3D57A00FQ38722710-11472088-5515-49B7-B32C-25CE13862BA5Q40873070-E57798C5-0D6F-45A3-9ADC-14D481C1BD48Q41477346-855F4DB6-543B-47A6-92AE-9D289E1DE738Q41549449-F0211B6F-627F-439D-AE0C-69D3D3459592Q41690384-395D17DB-DB46-4EC7-8233-9635F48C5877Q41739985-6CA5178D-C967-4F5E-B663-1FA117E6A6A1Q41829466-DFEB0202-14C6-424C-AD79-E74467609D34Q44253156-08C8BDB4-FB7C-426D-9D70-5C401A5B95A1Q44328155-3AEC6377-280B-43DE-A6C4-EE6CF0ED5000Q46386333-CE02A243-81E5-4E89-9B7E-F85B82CFAD3CQ47668726-A1C28EA8-6DA1-4CC0-9E79-A96E145549CCQ48338631-0B88F026-8A4C-4FB7-AEE1-23DEC6AA36E6Q50069449-7DC64B19-1671-4B40-B413-21760FFFA221Q50133941-7AEC762C-7BD8-4F6C-B29B-49FE448948B5Q51311110-72960C47-E0C8-4016-B27F-FC08BC191FB7Q52371445-6148A9CA-4E19-46B8-BFA9-00C0A13FF47AQ55342157-EA76C3A4-9D85-4F1B-AD0C-9C9711623E04Q57520814-799FA3D9-DBAB-4C8E-93B7-6A889005D569Q61793622-70CDF596-EDBC-4C4D-8094-FF2929E6BCE8Q61793640-CB018016-BAE3-43E0-A7A1-BC9ECD243E92Q61793642-3AEEAFD0-07C6-446D-BF5E-5A3F1362D3FAQ61793645-F2066A36-5136-44A9-B5E4-1CB1982C25A4Q61793647-6F3CC0B8-4204-472D-AC2A-390DB19F75ADQ61793663-7B2D08A4-8AC2-4F69-BC87-58CBDAAA22A9Q61793669-98402075-AD9C-48CC-9B7D-CC46122F5A79Q61793673-CE2601BA-C2A8-4D4B-BAE7-F4ADA389EE6EQ64066454-6DCC094F-860F-4629-8AB5-B76D3C8D1A13Q90148084-038B6DE0-CD94-4CC8-A065-2E46B5EAC7C9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Susan Jill Stocks
@ast
Susan Jill Stocks
@en
Susan Jill Stocks
@es
Susan Jill Stocks
@sl
type
label
Susan Jill Stocks
@ast
Susan Jill Stocks
@en
Susan Jill Stocks
@es
Susan Jill Stocks
@sl
altLabel
Jill Stocks
@en
prefLabel
Susan Jill Stocks
@ast
Susan Jill Stocks
@en
Susan Jill Stocks
@es
Susan Jill Stocks
@sl
P214
P106
P21
P214
P31
P496
0000-0001-6034-476X
P734
P735
P7859
viaf-104959895